Saved in:
| Main Authors: | , |
|---|---|
| Format: | Recurso digital |
| Language: | English |
| Published: |
Zenodo
2026
|
| Subjects: | |
| Online Access: | https://doi.org/10.5281/zenodo.20203033 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Table of Contents:
- <p> Objective. To analyze the immunological and regulatory basis of the 30-day interval between primary<br>rabies vaccination and virus-neutralizing antibody testing in dogs and cats intended for international travel.<br>Method. Technical review of rabies virus-neutralizing antibody (rVNA) kinetics, RFFIT and FAVN protocols,<br>and the regulatory frameworks of major destination countries. Results. The 30-day window corresponds to<br>the minimum period for the primary humoral response to reach the 0.5 IU/mL threshold required by<br>OIE/USDA standards. Non-compliance invalidates the serology result regardless of the titre obtained.<br>Conclusion. Strict adherence to this temporal window is decisive for the documentary validity of the export<br>file and the animal's admission at destination.</p>